The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long term follow-up analysis of plasma miR371 expression to detect early relapse in patients with clinical stage I testicular germ cell tumors on surveillance.
 
Lucia Nappi
Honoraria - AstraZeneca; Bayer; Ipsen; Merck Serono; Pfizer
Consulting or Advisory Role - AstraZeneca; Bayer; Ipsen; Pfizer
Research Funding - EMD Serono (Inst); Ipsen (Inst); Janssen Oncology (Inst)
Patents, Royalties, Other Intellectual Property - IVERMECTIN ANALOGUE COMPOUND THERAPEUTICS FOR HEAT SHOCK PROTEIN-27 (HSP27) INHIBITION, METHODS AND USES ASSOCIATED THEREWITH provisional number: 62/756,707
 
Neetu Saxena
No Relationships to Disclose
 
Sara Pautasso
No Relationships to Disclose
 
Sylwia Mazurek
No Relationships to Disclose
 
Guliz Ozgun
No Relationships to Disclose
 
Catarina Kollmannsberger
No Relationships to Disclose
 
Max Trottier Chi
No Relationships to Disclose
 
Antoine Morin Coulombe
No Relationships to Disclose
 
Maryam Soleimani
Honoraria - Ipsen; Pfizer
Consulting or Advisory Role - Bayer
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bayer (Inst)
 
Kim N. Chi
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; POINT Biopharma; Roche
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Constellation Pharmaceuticals; Daiichi Sankyo; ESSA; Janssen; Merck; POINT Biopharma; Roche; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); ESSA (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Expert Testimony - AstraZeneca; Novartis
 
Bernhard J. Eigl
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb/Pfizer; EMD Serono/Merck; Gilead Sciences; Janssen; Pfizer; Roche Canada; Seagen
Consulting or Advisory Role - EMD Serono; Gilead Sciences
Travel, Accommodations, Expenses - EMD Serono
 
Peter C. Black
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Biosyent; Bristol-Myers Squibb; EMD Serono; Ferring; Janssen Oncology; Merck; Minogue Medical; miR Scientific; Nonagen Bioscience; Pfizer; Prokarium; Protara Therapeutics; Protara Therapeutics; QED Therapeutics; Roche Canada; Sanofi; Sesen Bio; STIMIT; TerSera; Tolmar; Urogen pharma; Verity Pharmaceuticals
Speakers' Bureau - Bayer; BioSyent; Pfizer; TerSera
Research Funding - iProgen
Patents, Royalties, Other Intellectual Property - 1. PCT/CA2014/000787. Canada. 2014-11-03 Cancer Biomarkers and Classifiers and uses thereof. 2. #61899648 United States. 2013-03-13 Bladder cancer signature.
 
Alan I. So
No Relationships to Disclose
 
Martin Gleave
Stock and Other Ownership Interests - Sustained Therapeutics
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen; Pfizer; Roche; Sanofi; Tersera
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Genova Diagnostics; Janssen; Pfizer; Roche; Sanofi; Tersera
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - ST-CP; ST-POP
 
Sean Kern
No Relationships to Disclose
 
Siamak Daneshmand
Stock and Other Ownership Interests - Taris
Honoraria - Aduro Biotech; Allergan (I); Bristol-Myers Squibb; Ferring; Janssen; Johnson & Johnson; Olympus; pacific edge; Photocure; QED Therapeutics
Consulting or Advisory Role - Ferring; Photocure; QED Therapeutics; Taris
Research Funding - Photocure
Travel, Accommodations, Expenses - Photocure
 
Nabil Adra
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol Myers Squibb Foundation; Bristol Myers Squibb Foundation; Exelixis; Merck; Sanofi
Research Funding - Exelixis (Inst); Genentech (Inst); Merck (Inst); Natera (Inst)
 
Lawrence H. Einhorn
Stock and Other Ownership Interests - Amgen
 
Craig R. Nichols
No Relationships to Disclose
 
Christian K. Kollmannsberger
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen Oncology; Merck; Merck KGaA; Pfizer
Consulting or Advisory Role - AAA/Endocyte/Novartis; Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; Ipsen; Janssen; Merck; Merck KGaA; Pfizer
Travel, Accommodations, Expenses - Ipsen; Janssen Oncology; Pfizer